297 related articles for article (PubMed ID: 29775756)
21. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
22. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
23. SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth.
Park SH; Ozden O; Liu G; Song HY; Zhu Y; Yan Y; Zou X; Kang HJ; Jiang H; Principe DR; Cha YI; Roh M; Vassilopoulos A; Gius D
Cancer Res; 2016 Jul; 76(13):3802-12. PubMed ID: 27197174
[TBL] [Abstract][Full Text] [Related]
24. The role of PKM2 in cancer progression and its structural and biological basis.
Wu B; Liang Z; Lan H; Teng X; Wang C
J Physiol Biochem; 2024 May; 80(2):261-275. PubMed ID: 38329688
[TBL] [Abstract][Full Text] [Related]
25. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose.
Li X; Deng S; Liu M; Jin Y; Zhu S; Deng S; Chen J; He C; Qin Q; Wang C; Zhao G
Cell Death Dis; 2018 Jan; 9(2):133. PubMed ID: 29374159
[TBL] [Abstract][Full Text] [Related]
26. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
[TBL] [Abstract][Full Text] [Related]
27. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
Konno M; Hamabe A; Doki Y; Mori M; Ishii H
Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
[TBL] [Abstract][Full Text] [Related]
28. PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.
Liu F; Ma F; Wang Y; Hao L; Zeng H; Jia C; Wang Y; Liu P; Ong IM; Li B; Chen G; Jiang J; Gong S; Li L; Xu W
Nat Cell Biol; 2017 Nov; 19(11):1358-1370. PubMed ID: 29058718
[TBL] [Abstract][Full Text] [Related]
29. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
[TBL] [Abstract][Full Text] [Related]
30. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
[TBL] [Abstract][Full Text] [Related]
31. Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth.
Xiangyun Y; Xiaomin N; Linping G; Yunhua X; Ziming L; Yongfeng Y; Zhiwei C; Shun L
Oncotarget; 2017 Jan; 8(4):6984-6993. PubMed ID: 28036303
[TBL] [Abstract][Full Text] [Related]
32. Interdependence of GLO I and PKM2 in the Metabolic shift to escape apoptosis in GLO I-dependent cancer cells.
Shimada N; Takasawa R; Tanuma SI
Arch Biochem Biophys; 2018 Jan; 638():1-7. PubMed ID: 29225125
[TBL] [Abstract][Full Text] [Related]
33. Glucose restriction reverses the Warburg effect and modulates PKM2 and mTOR expression in breast cancer cell lines.
Tahtouh R; Wardi L; Sarkis R; Hachem R; Raad I; El Zein N; Hilal G
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):26-33. PubMed ID: 31880514
[TBL] [Abstract][Full Text] [Related]
34. Vacuolar H
Son SW; Chau GC; Kim ST; Um SH
Cells; 2019 Sep; 8(10):. PubMed ID: 31554233
[TBL] [Abstract][Full Text] [Related]
35. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
Li S; Ji X; Wang R; Miao Y
Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
[TBL] [Abstract][Full Text] [Related]
36. Dual roles of PKM2 in cancer metabolism.
Wu S; Le H
Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):27-35. PubMed ID: 23212076
[TBL] [Abstract][Full Text] [Related]
37. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
Li H; Yan M; Wu X; Wang Y; Huang L
Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
[TBL] [Abstract][Full Text] [Related]
38. Emerging roles of PKM2 in cell metabolism and cancer progression.
Luo W; Semenza GL
Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
[TBL] [Abstract][Full Text] [Related]
39. Structural insight into mechanisms for dynamic regulation of PKM2.
Wang P; Sun C; Zhu T; Xu Y
Protein Cell; 2015 Apr; 6(4):275-287. PubMed ID: 25645022
[TBL] [Abstract][Full Text] [Related]
40. Pyruvate Kinase Isozyme M2 Plays a Critical Role in the Interactions Between Pancreatic Stellate Cells and Cancer Cells.
Masamune A; Hamada S; Yoshida N; Nabeshima T; Shimosegawa T
Dig Dis Sci; 2018 Jul; 63(7):1868-1877. PubMed ID: 29619774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
